Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1977 1
1981 2
1982 4
1983 5
1984 9
1985 4
1986 8
1987 3
1988 8
1989 6
1990 3
1991 3
1992 7
1993 7
1994 15
1995 10
1996 10
1997 5
1998 6
1999 5
2000 15
2001 10
2002 8
2003 13
2004 12
2005 12
2006 9
2007 15
2008 13
2009 21
2010 23
2011 24
2012 23
2013 26
2014 35
2015 46
2016 51
2017 44
2018 62
2019 78
2020 80
2021 72
2022 20
2023 25
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

765 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Leukemia, acute myeloid, susceptibility to"
Page 1
Advances in acute myeloid leukemia.
Newell LF, Cook RJ. Newell LF, et al. BMJ. 2021 Oct 6;375:n2026. doi: 10.1136/bmj.n2026. BMJ. 2021. PMID: 34615640 Review.
Acute myeloid leukemia (AML) is an uncommon but potentially catastrophic diagnosis with historically high mortality rates. The standard of care treatment remained unchanged for decades; however, recent discoveries of molecular drivers of leukemogenesis and
Acute myeloid leukemia (AML) is an uncommon but potentially catastrophic diagnosis with historically high mortality rat
Leukemia.
Juliusson G, Hough R. Juliusson G, et al. Prog Tumor Res. 2016;43:87-100. doi: 10.1159/000447076. Epub 2016 Sep 5. Prog Tumor Res. 2016. PMID: 27595359 Review.
Leukemias are a group of life threatening malignant disorders of the blood and bone marrow. In the adolescent and young adult (AYA) population, the acute leukemias are most prevalent, with chronic myeloid leukemia being infrequently seen. ...This chapter revi …
Leukemias are a group of life threatening malignant disorders of the blood and bone marrow. In the adolescent and young adult (AYA) populati …
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA. Ullmann AJ, et al. Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12. Clin Microbiol Infect. 2018. PMID: 29544767 Free article.
Pathogen identification to species complex level is strongly recommended for all clinically relevant Aspergillus isolates; antifungal susceptibility testing should be performed in patients with invasive disease in regions with resistance found in contemporary survei …
Pathogen identification to species complex level is strongly recommended for all clinically relevant Aspergillus isolates; antifungal sus
Molecular biomarkers in acute myeloid leukemia.
Prada-Arismendy J, Arroyave JC, Röthlisberger S. Prada-Arismendy J, et al. Blood Rev. 2017 Jan;31(1):63-76. doi: 10.1016/j.blre.2016.08.005. Epub 2016 Sep 2. Blood Rev. 2017. PMID: 27639498 Review.
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. ...This review summarizes the most relevant molecular (genetic, epigenetic, and protein) biomarkers associated with acute myeloid leukemia and discuss
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. ...This review summarizes the m
Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
Walcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strauß A, Blaudszun AR, Yevsa T, Fricke S, Kossatz-Boehlert U. Walcher L, et al. Front Immunol. 2020 Aug 7;11:1280. doi: 10.3389/fimmu.2020.01280. eCollection 2020. Front Immunol. 2020. PMID: 32849491 Free PMC article. Review.
In particular, the analysis of biomarkers in cancer patients within the pre- and post-therapeutic period is required to identify several types of cells, which carry a risk for a disease progression and subsequent post-therapeutic relapse. Cancer stem cells (CSCs) are a sub …
In particular, the analysis of biomarkers in cancer patients within the pre- and post-therapeutic period is required to identify several typ …
Updates on targeted therapies for acute myeloid leukaemia.
Kayser S, Levis MJ. Kayser S, et al. Br J Haematol. 2022 Jan;196(2):316-328. doi: 10.1111/bjh.17746. Epub 2021 Aug 4. Br J Haematol. 2022. PMID: 34350585 Review.
In the past few years research in the underlying pathogenic mechanisms of acute myeloid leukaemia (AML) has led to remarkable advances in our understanding of the disease. ...Our increased understanding of the pathogenesis of AML facilitated by next-generatio …
In the past few years research in the underlying pathogenic mechanisms of acute myeloid leukaemia (AML) has led to remarkable …
NPM1-mutated acute myeloid leukemia: from bench to bedside.
Falini B, Brunetti L, Sportoletti P, Martelli MP. Falini B, et al. Blood. 2020 Oct 8;136(15):1707-1721. doi: 10.1182/blood.2019004226. Blood. 2020. PMID: 32609823 Free article. Review.
NPM1 mutations represent the most common genetic lesion in adult acute myeloid leukemia (AML; about one third of cases), and they act deterministically to cause the aberrant cytoplasmic delocalization of NPM1 mutants. ...Finally, we address the value and limi …
NPM1 mutations represent the most common genetic lesion in adult acute myeloid leukemia (AML; about one third of cases) …
Genetics of MDS.
Ogawa S. Ogawa S. Blood. 2019 Mar 7;133(10):1049-1059. doi: 10.1182/blood-2018-10-844621. Epub 2019 Jan 22. Blood. 2019. PMID: 30670442 Free PMC article. Review.
Among major mutational targets in MDS are the molecules involved in DNA methylations, chromatin modification, RNA splicing, transcription, signal transduction, cohesin regulation, and DNA repair. Showing substantial overlaps with driver mutations seen in acute myeloid
Among major mutational targets in MDS are the molecules involved in DNA methylations, chromatin modification, RNA splicing, transcription, s …
Pediatric Myelodysplastic Syndromes.
Patel SS. Patel SS. Clin Lab Med. 2021 Sep;41(3):517-528. doi: 10.1016/j.cll.2021.03.015. Epub 2021 Jun 24. Clin Lab Med. 2021. PMID: 34304779 Review.
Approximately 30% to 45% of pediatric MDS cases are associated with an underlying genetic predisposition syndrome. A subset of patients present with MDS/acute myeloid leukemia (AML) following intensive chemotherapy for an unrelated malignancy. ...
Approximately 30% to 45% of pediatric MDS cases are associated with an underlying genetic predisposition syndrome. A subset of patients pres …
Hematologic malignancies and Li-Fraumeni syndrome.
Swaminathan M, Bannon SA, Routbort M, Naqvi K, Kadia TM, Takahashi K, Alvarado Y, Ravandi-Kashani F, Patel KP, Champlin R, Kantarjian H, Strong L, DiNardo CD. Swaminathan M, et al. Cold Spring Harb Mol Case Stud. 2019 Feb 1;5(1):a003210. doi: 10.1101/mcs.a003210. Print 2019 Feb. Cold Spring Harb Mol Case Stud. 2019. PMID: 30709875 Free PMC article. Review.
LFS is related to germline mutations of the tumor-suppressor gene TP53 The most common reported leukemia associated with LFS is hypodiploid acute lymphoblastic leukemia, but myeloid malignancies including acute myeloid leukemia (AM …
LFS is related to germline mutations of the tumor-suppressor gene TP53 The most common reported leukemia associated with LFS is hypod …
765 results